Advanced Oncotherapy Plc announced that following the continued successful development of the company's first LIGHT system and the recent industrialization agreement with Thales, the board has decided to realign the roles and responsibilities of the Executive team to add additional focus to both operational functions and ongoing sales and business development. As a result, and with immediate effect, Michael Sinclair, currently Executive Chairman, will become Chief Executive Officer and Executive Chairman; Sanjeev Pandya, currently Chief Executive Officer, will become Executive Vice President for Global Business Development and will remain on the Board of the company. Nicolas Serandour, currently Chief Financial Officer, will become Chief Operating and Financial Officer.